Science & Enterprise subscription

Follow us on Twitter

  • FDA today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor n… https://t.co/C8uIamFD3C
    about 14 hours ago
  • New post on Science and Enterprise: FDA Approves Rare Infant Disease Gene Therapy https://t.co/wqx9iCTxVe #Science #Business
    about 14 hours ago
  • FDA Approves First Mesothelioma Treatment in 15 Years https://t.co/PnKrL24HW0 via @medscape ATTN: @innerarchitect @deansguide
    about 18 hours ago
  • A neuroscience lab in the U.K. designed a process using virtual reality to detect early-stage Alzheimer's disease i… https://t.co/SrIZhdhyLJ
    about 18 hours ago
  • New post on Science and Enterprise: Virtual Reality Harnessed to Detect Alzheimer’s https://t.co/tJrT1Q6LsE #Science #Business
    about 18 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

FDA Approves Rare Infant Disease Gene Therapy

Neurons

The Food and Drug Administration today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor neurons with a healthy one. . . . → Read More: FDA Approves Rare Infant Disease Gene Therapy

Viral Disease Biotech Joins ElevateBio, Gains $120M

T-cells illustration

A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M

Start-Up to Use Stem Cells for Hearing Loss

Headphones

A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss. . . . → Read More: Start-Up to Use Stem Cells for Hearing Loss

Trial Shows Surgical Pain Managed Without Opioids

Head in hands

Results from a clinical trial show patients recovered from their hernia surgeries with non-opioid pain medications, and stayed off opioids for 15 days. . . . → Read More: Trial Shows Surgical Pain Managed Without Opioids

Genomic Analysis Finds Lost Tomato Taste Gene

Tomato genetics

An analysis of genomes for all varieties of tomatoes, both wild and domesticated, found a rare gene variation that can make tomatoes tastier. . . . → Read More: Genomic Analysis Finds Lost Tomato Taste Gene

Company Helps Labs Build Gene, Cell Therapy Businesses

DNAmolcule model

A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs. . . . → Read More: Company Helps Labs Build Gene, Cell Therapy Businesses

FDA Issues Final Biosimilar Guidance

Pills and dollar bill

The Food and Drug Administration issued its final guidance on regulating the interchangeability of so-called biosimilars with original biologic drugs. . . . → Read More: FDA Issues Final Biosimilar Guidance

Scorpion-Derived Peptide Lights Up Brain Tumors

Results from a clinical trial show a peptide derived from scorpion venom illuminates brain tumor cells making removal of the tumors easier for surgeons. . . . → Read More: Scorpion-Derived Peptide Lights Up Brain Tumors

Companies Partner on Kidney Disease in $2B Deal

Goldfinch

A collaboration between biopharmaceutical maker Gilead Sciences and biotechnology company Goldfinch Bio aims to develop precision medicines for treating various kidney diseases. . . . → Read More: Companies Partner on Kidney Disease in $2B Deal

Start-Up to Use Crispr for Heart Disease, Gains $59M

Editing DNA

A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease. . . . → Read More: Start-Up to Use Crispr for Heart Disease, Gains $59M